. .. ????????????????, Définition de la dénutrition????, p.46

, Critère de jugement principal????????????????????, p.46

, Critères de jugement secondaires, p.46

, Caractéristiques de la population incluse????????????????, vol.48, p.57

, -La réponse au traitement par immunothérapie selon les critères RECIST version 1.1 -Les effets indésirables secondaire à l'immunothérapie

. Binder-foucard, . Florence, . Belot, . Aurélien, . Delafosse et al., Estimation nationale de l'incidence et de la mortalité par cancer en France entre 1980 et 2012 : Etude à partir des registres des cancers du réseau Francim. Partie 1 -Tumeurs solides, 2013.

L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-tieulent et al., Global cancer statistics, 2012: Global Cancer Statistics, CA Cancer J Clin. mars, vol.65, issue.2, pp.87-108, 2012.

, Projection de l'incidence et de la mortalité par cancer en France métropolitaine en 2017, p.80

A. Cowppli-bony, . Uhry, . Zoé, . Remontet, . Laurent et al., Survie des personnes atteintes de cancer en France métropolitaine 1983-2013 -Etude à partir des registres des cancers du réseau Francim. Partie 1 -Tumeurs solides, Synthère. févr, 2016.

P. Goldstraw, K. Chansky, J. Crowley, R. Rami-porta, H. Asamura et al., The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. janv, vol.11, issue.1, pp.39-51, 2016.

D. Cruz, C. S. Tanoue, L. T. Matthay, and R. A. , Lung Cancer: Epidemiology, Etiology, and Prevention, Clin Chest Med. déc, vol.32, issue.4, pp.605-649, 2011.

M. R. Spitz, W. K. Hong, C. I. Amos, X. Wu, M. B. Schabath et al., A Risk Model for Prediction of Lung Cancer, JNCI J Natl Cancer Inst. 2 mai, vol.99, issue.9, pp.715-741, 2007.

F. Nyberg, P. Gustavsson, L. Jarup, T. Bellander, N. Berglind et al., Urban Air Pollution and Lung Cancer in Stockholm, vol.11, p.9, 2000.

T. Driscoll, D. I. Nelson, K. Steenland, J. Leigh, M. Concha-barrientos et al., The global burden of disease due to occupational carcinogens, Am J Ind Med. déc, vol.48, issue.6, pp.419-450, 2005.

W. Weiss, Asbestosis: A Marker for the Increased Risk of Lung Cancer Among Workers Exposed to Asbestos, Chest. févr, vol.115, issue.2, pp.536-585, 1999.

J. Lortet-tieulent, I. Soerjomataram, J. Ferlay, M. Rutherford, E. Weiderpass et al., International trends in lung cancer incidence by histological subtype: Adenocarcinoma stabilizing in men but still increasing in women, Lung Cancer. avr, vol.84, issue.1, pp.13-22, 2014.

S. Sun, J. H. Schiller, and A. F. Gazdar, Lung cancer in never smokers -a different disease, Nat Rev Cancer, vol.7, issue.10, pp.778-90, 2007.

S. G. Spiro, M. K. Gould, and G. L. Colice, Initial Evaluation of the Patient With Lung Cancer: Symptoms, Signs, Laboratory Tests, and Paraneoplastic Syndromes, Chest. sept, vol.132, issue.3, pp.149-160, 2007.

D. S. Couraud, A. Toffart, and P. Souquet, Référentiel en oncologie Auvergne -Rhône-Alpes. Cancer bronchique non à petites cellules. 14ème édition, p.57

R. Rami-porta, V. Bolejack, J. Crowley, D. Ball, J. Kim et al., The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer, J Thorac Oncol. juill, vol.10, issue.7, pp.990-1003, 2015.

H. Asamura, K. Chansky, J. Crowley, P. Goldstraw, V. W. Rusch et al., The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer, J Thorac Oncol. déc, vol.10, issue.12, pp.1675-84, 2015.

W. Eberhardt, A. Mitchell, J. Crowley, H. Kondo, Y. T. Kim et al., The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer, J Thorac Oncol, vol.10, issue.11, pp.1515-1537, 2015.

A. Steven, S. A. Fisher, and B. W. Robinson, Immunotherapy for lung cancer: Immunotherapy for lung cancer, Respirology. juill, vol.21, issue.5, pp.821-854, 2016.

D. S. Chen and I. Mellman, Oncology Meets Immunology: The Cancer-Immunity Cycle, Immunity. juill, vol.39, issue.1, pp.1-10, 2013.

P. S. Linsley, Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation, J Exp Med. 1 mars, vol.173, issue.3, pp.721-751, 1991.

P. S. Linsley, W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle et al., CTLA-4 is a second receptor for the B cell activation antigen B7, J Exp Med. 1 sept, vol.174, issue.3, pp.561-570, 1991.

T. J. Lynch, I. Bondarenko, A. Luft, P. Serwatowski, F. Barlesi et al., Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non-Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study, J Clin Oncol. 10 juin, vol.30, issue.17, pp.2046-54, 2012.

R. Govindan, A. Szczesna, M. Ahn, C. Schneider, G. Mella et al., Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer, J Clin Oncol, vol.35, issue.30, pp.3449-57, 2017.

M. D. Hellmann, L. Paz-ares, B. Caro, R. Zurawski, B. Kim et al., Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer, N Engl J Med, vol.28, 2019.

G. J. Freeman, A. J. Long, Y. Iwai, K. Bourque, T. Chernova et al., Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation, J Exp Med, vol.192, issue.7, pp.1027-1061, 2000.

H. Dong, S. E. Strome, D. R. Salomao, H. Tamura, F. Hirano et al., Tumorassociated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion, Nat Med. août, vol.8, issue.8, pp.793-800, 2002.

C. Mu, J. Huang, Y. Chen, C. Chen, and X. Zhang, High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation, Med Oncol. sept, vol.28, issue.3, pp.682-690, 2011.

J. Brahmer, K. L. Reckamp, P. Baas, L. Crinò, W. Eberhardt et al., Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer, N Engl J Med. 9 juill, vol.373, issue.2, pp.123-158, 2015.

H. Borghaei, L. Paz-ares, L. Horn, D. R. Spigel, M. Steins et al., Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer, N Engl J Med, vol.373, issue.17, pp.1627-1666, 2015.

R. S. Herbst, P. Baas, D. Kim, E. Felip, J. L. Pérez-gracia et al., Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial, The Lancet. avr, vol.387, pp.1540-50, 2016.

M. Reck, D. Rodríguez-abreu, A. G. Robinson, R. Hui, T. Cs?szi et al., Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer, N Engl J Med, vol.375, issue.19, pp.1823-1856, 2016.

T. Mok, Y. Wu, I. Kudaba, D. M. Kowalski, B. C. Cho et al., Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial. The Lancet, vol.393, pp.1819-1849, 2019.

L. Gandhi, D. Rodríguez-abreu, S. Gadgeel, E. E. Felip, E. et al., Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer, N Engl J Med. 31 mai, vol.378, issue.22, pp.2078-92, 2018.

L. Paz-ares, A. Luft, D. Vicente, A. Tafreshi, M. Gümü? et al., Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer, N Engl J Med, vol.379, issue.21, pp.2040-51, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02345238

S. J. Antonia, A. Villegas, D. Daniel, D. Vicente, S. Murakami et al., Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer, N Engl J Med, vol.377, issue.20, pp.1919-1948, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01753457

S. J. Antonia, A. Villegas, D. Daniel, D. Vicente, S. Murakami et al., Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC, N Engl J Med. 13 déc, vol.379, issue.24, pp.2342-50, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02284390

A. Rittmeyer, F. Barlesi, D. Waterkamp, K. Park, F. Ciardiello et al., Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. The Lancet, vol.389, pp.255-65, 2017.

F. Barlesi, J. Vansteenkiste, D. Spigel, H. Ishii, M. Garassino et al., Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study, Lancet Oncol. nov, vol.19, issue.11, pp.1468-79, 2018.

A. B. Patel and O. Pacha, Skin Reactions to Immune Checkpoint Inhibitors, Naing A, Hajjar J, éditeurs. Immunotherapy, pp.175-84, 2017.

R. Barroso-sousa, W. T. Barry, A. C. Garrido-castro, F. S. Hodi, L. Min et al., Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis, JAMA Oncol. 1 févr, vol.4, issue.2, p.173, 2018.

M. Nishino, A. Giobbie-hurder, H. Hatabu, N. H. Ramaiya, and F. S. Hodi, Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis, JAMA Oncol. 1 déc, vol.2, issue.12, p.1607, 2016.

I. Baraibar, I. Melero, M. Ponz-sarvise, and E. Castanon, Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer, Drug Saf. févr, vol.42, issue.2, pp.281-94, 2019.

. Anaes, Evaluation diagnostique de la dénutrition protéino-énergétique des adultes hospitalisés, Acta Endosc. sept, vol.28, issue.2, pp.151-156, 2003.

R. G. Whitehead and G. Alleyne, Pathophysiological factors of importance in proteincalorie malnutrition, Br Med Bull. janv, vol.28, issue.1, pp.72-80, 1972.

D. Cicely, B. M. Williams, and . Kwashiorkor, The Lancet, 1933.

M. R. Corkins, P. Guenter, R. A. Dimaria-ghalili, G. L. Jensen, A. Malone et al., Malnutrition Diagnoses in Hospitalized Patients: United States, J Parenter Enter Nutr. févr, vol.38, issue.2, pp.186-95, 2010.

K. Norman, C. Pichard, H. Lochs, and M. Pirlich, Prognostic impact of disease-related malnutrition, Clin Nutr. févr, vol.27, issue.1, pp.5-15, 2008.

M. Pirlich, T. Schütz, M. Kemps, N. Luhman, N. Minko et al., Social risk factors for hospital malnutrition, Nutrition. mars, vol.21, issue.3, pp.295-300, 2005.

, Stratégie de prise en charge en cas de dénutrition protéino-énergétique chez la personne âgée. HAS, 2007.

J. V. White, P. Guenter, G. Jensen, A. Malone, and M. Schofield, Academy Malnutrition Work Group, et al. Consensus Statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: Characteristics Recommended for the Identification and Documentation of Adult Malnutrition (Undernutrition), J Parenter Enter Nutr. mai, vol.36, issue.3, pp.275-83, 2012.

T. Cederholm, I. Bosaeus, R. Barazzoni, J. Bauer, A. Van-gossum et al., Diagnostic criteria for malnutrition -An ESPEN Consensus Statement, Clin Nutr. juin, vol.34, issue.3, pp.335-375, 2015.

G. A. Eknoyan and . Quetelet, 1874) the average man and indices of obesity, Nephrol Dial Transplant. 17 août, vol.23, issue.1, pp.47-51, 1796.

, Physical status: the use and interpretation of anthropometry, World Health Organ Tech Rep Ser, vol.854

H. O. Studley, Percentage of weight loss, a basic indicators of surgical risk in patients with chronic peptic ulcer, JAMA. 8 févr, vol.106, issue.6, pp.458-60, 1936.

W. D. Dewys, C. Begg, P. T. Lavin, P. R. Band, J. M. Bennett et al., Prognostic effect of weight loss prior tochemotherapy in cancer patients, Am J Med, vol.69, issue.4, pp.491-498, 1980.

K. Rosenbaum, J. Wang, R. N. Pierson, and D. P. Kotler, Time-Dependent Variation in Weight and Body Composition in Healthy Adults, J Parenter Enter Nutr. mars, vol.24, issue.2, pp.52-57, 2000.

D. B. Morgan, M. R. Path, G. L. Hill, and L. Burkinshaw, The assessment of weight loss from a single measurement of body weight: the problems and limitations, Am J Clin Nutr, vol.33, pp.2101-2106, 1980.

G. Fanali, A. Di-masi, V. Trezza, M. Marino, M. Fasano et al., Human serum albumin: From bench to bedside, Mol Aspects Med. juin, vol.33, issue.3, pp.209-90, 2012.

D. Rigaud, I. Tallonneau, M. Brindisi, and B. Vergès, Prognosis in 41 severely malnourished anorexia nervosa patients, Clin Nutr, vol.31, issue.5, pp.693-701, 2012.

A. Keys, J. Brozek, A. Henschel, O. Mickelsen, and H. L. Taylor, The Biology of Human Starvation I-II, 1950.

A. Fleck, . Raines, . Gail, . Hawker, . Felicity et al., Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury, The Lancet. 6 avr, pp.781-785, 1985.

B. Ballmer-weber, R. Dummer, E. Küng, G. Burg, and P. Ballmer, Interleukin 2-induced increase of vascular permeability without decrease of the intravascular albumin pool, Br J Cancer. janv, vol.71, issue.1, pp.78-82, 1995.

J. Vincent, M. Dubois, R. J. Navickis, and M. M. Wilkes, Hypoalbuminemia in Acute Illness: Is There a Rationale for Intervention?: A Meta-Analysis of Cohort Studies and Controlled Trials, Ann Surg. mars, vol.237, issue.3, pp.319-353, 2003.

F. B. Seibert, J. Nelson, and . Walter, Electrophoretic study of the blood protein response in tuberculosis, J Biol Chem, vol.143, pp.29-38, 1942.

S. Goodman, R. E. Canfield, and F. J. Morgan, The Amino Acid Sequence of Human Plasma Prealbumin, p.11

P. Felding and G. Fex, Cellular origin of prealbumin in the rat, Biochim Biophys Acta BBA -Gen Subj. juin, vol.716, issue.3, pp.446-455, 1982.

S. L. Aleshire, C. A. Bradley, L. D. Richardson, and F. F. Parl, Localization of human prealbumin in choroid plexus epithelium, J Histochem Cytochem. mai, vol.31, issue.5, pp.608-620, 1983.

E. L. Socolow, K. A. Woeber, R. H. Purdy, M. T. Holloway, and S. H. Ingbar, Preparation of I-131-labeled human serum prealbumin and its metabolism in normal and sick patients, J Clin Invest, vol.44, issue.10, pp.1600-1609, 1965.

F. R. Smith and D. S. Goodman, The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma, J Clin Invest, vol.50, issue.11, pp.2426-2462, 1971.

M. Vieira and M. J. Saraiva, Transthyretin: a multifaceted protein, Biomol Concepts. 1 janv, vol.5, issue.1, 2014.

Y. Ingenbleek, M. De-visscher, and P. De-nayer, Measurement of prealbumin as index of protein-calorie malnutrition. The Lancet. 15 juill 1972, pp.106-115

R. E. Banks, M. A. Forbes, M. Storr, J. Higginson, D. Thompson et al., The acute phase protein response in patients receiving subcutaneous IL-6, Clin Exp Immunol. 28 juin, vol.102, issue.1, pp.217-240, 2008.

M. J. Tapia, J. Ocón, C. Cabrejas-gómez, M. D. Ballesteros-pomar, A. Vidal-casariego et al., Nutrition-related risk indexes and long-term mortality in noncritically ill inpatients who receive total parenteral nutrition (prospective multicenter study), Clin Nutr, vol.34, issue.5, pp.962-969, 2015.

Y. Guigoz, B. Vellas, and P. J. Garry, Assessing the Nutritional Status of the Elderly: The Mini Nutritional Assessment as Part of the Geriatric Evaluation, Nutr Rev. 27 avr, vol.54, issue.1, pp.59-65, 2009.

L. Z. Rubenstein, J. O. Harker, A. Salva, Y. Guigoz, and B. Vellas, Screening for Undernutrition in Geriatric Practice: Developing the Short-Form Mini-Nutritional Assessment (MNA-SF), J Gerontol A Biol Sci Med Sci. 1 juin, vol.56, issue.6, pp.366-72, 2001.

R. Rizzoli, Does the Mini Nutritional Assessment predict hospitalization outcomes in older people, p.6

L. P. Novak, Aging, Total Body Potassium, Fat-free Mass, and Cell Mass in Males and Females Between Ages 18 and 85 Years, J Gerontol, vol.27, issue.4, pp.438-481, 1972.

Y. Schutz, U. Kyle, and C. Pichard, Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98, Int J Obes. juill, vol.26, issue.7, pp.953-60, 2002.

J. Durnin and J. Womersley, Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 Years, Br J Nutr. juill, vol.32, issue.01, pp.77-97, 1974.

U. Kyle, Bioelectrical impedance analysis?part I: review of principles and methods, Clin Nutr, vol.23, issue.5, pp.1226-1269, 2004.

A. J. Cruz-jentoft, J. P. Baeyens, J. M. Bauer, Y. Boirie, T. Cederholm et al., European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People, Age Ageing. 1 juill, vol.39, issue.4, pp.412-435, 2010.

M. Borga, J. West, J. D. Bell, N. C. Harvey, T. Romu et al., Advanced body composition assessment: from body mass index to body composition profiling, J Investig Med. juin, vol.66, issue.5, pp.1-10, 2018.

X. Hébuterne, E. Lemarié, M. Michallet, C. B. De-montreuil, S. M. Schneider et al., Prevalence of Malnutrition and Current Use of Nutrition Support in Patients With Cancer, J Parenter Enter Nutr. févr, vol.38, issue.2, pp.196-204, 2014.

A. K. Taylor, W. Cao, K. P. Vora, J. Cruz, W. Shieh et al., Protein Energy Malnutrition Decreases Immunity and Increases Susceptibility to Influenza Infection in Mice, J Infect Dis. 1 févr, vol.207, issue.3, pp.501-511, 2013.

O. Najera, C. Gonzalez, G. Toledo, L. Lopez, and R. Ortiz, Flow Cytometry Study of Lymphocyte Subsets in Malnourished and Well-Nourished Children with Bacterial Infections, Clin Vaccine Immunol. 1 mai, vol.11, issue.3, pp.577-80, 2004.

C. González-torres, H. González-martínez, A. Miliar, O. Nájera, J. Graniel et al., Effect of Malnutrition on the Expression of Cytokines Involved in Th1 Cell Differentiation, Nutrients. 19 févr, vol.5, issue.2, pp.579-93, 2013.

H. González-martínez, L. Rodríguez, O. Nájera, D. Cruz, A. Miliar et al., Expression of Cytokine mRNA in Lymphocytes of Malnourished Children, J Clin Immunol. sept, vol.28, issue.5, pp.593-602, 2008.

C. Kubo, A. Gajar, B. C. Johnson, and R. A. Good, The effects of dietary restriction on immune function and development of autoimmune disease in BXSB mice, Proc Natl Acad Sci. 1 avr, vol.89, issue.7, pp.3145-3154, 1992.

L. Piccio, J. L. Stark, and A. H. Cross, Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis, J Leukoc Biol, vol.84, issue.4, pp.940-948, 2008.

R. C. Frederich, B. Löllmann, A. Hamann, A. Napolitano-rosen, B. B. Kahn et al., Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity, J Clin Invest. 1 sept, vol.96, issue.3, pp.1658-63, 1995.

R. S. Ahima, D. Prabakaran, C. Mantzoros, . Qu, . Daqing et al., Role of leptin in the neuroendocrine response to fasting, Nature. 18 juill, vol.382, pp.250-252, 1996.

L. Martin, P. Senesse, I. Gioulbasanis, S. Antoun, F. Bozzetti et al., Diagnostic Criteria for the Classification of Cancer-Associated Weight Loss, J Clin Oncol. janv, vol.33, issue.1, pp.90-99, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02276651

S. S. Shachar, G. R. Williams, H. B. Muss, and T. F. Nishijima, Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review, Eur J Cancer. avr, vol.57, pp.58-67, 2016.

M. Barret, D. Malka, T. Aparicio, C. Dalban, C. Locher et al., Nutritional Status Affects Treatment Tolerability and Survival in Metastatic Colorectal Cancer Patients: Results of an AGEO Prospective Multicenter Study, Oncology, vol.81, issue.5-6, pp.395-402, 2011.

P. J. Ross, S. Ashley, A. Norton, K. Priest, J. S. Waters et al., Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?, Br J Cancer. mai, vol.90, issue.10, pp.1905-1916, 2004.

D. Fiore, F. Lecleire, S. Pop, D. Rigal, O. Hamidou et al., Baseline Nutritional Status Is Predictive of Response to Treatment and Survival in Patients Treated by Definitive Chemoradiotherapy for a Locally Advanced Esophageal Cancer, Am J Gastroenterol, vol.102, issue.11, pp.2557-63, 2007.

L. Lin, J. Zhao, J. Hu, F. Huang, J. Han et al., Impact of Weight Loss at Presentation on Survival in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) Sensitive Mutant Advanced Non-small Cell Lung Cancer (NSCLC) Treated with First-line EGFR-TKI, J Cancer, vol.9, issue.3, pp.528-562, 2018.

S. Rossi, D. Noia, V. Tonetti, L. Strippoli, A. Basso et al., Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?, Future Oncol. avr, vol.14, issue.10, pp.919-945, 2018.

N. Ueno, S. Banno, Y. Endo, M. Tamura, K. Sugaya et al., Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings, Jpn J Clin Oncol. 1 juill, vol.49, issue.7, pp.676-86, 2019.

A. Cortellini, L. Verna, G. Porzio, F. Bozzetti, P. Palumbo et al., Predictive value of skeletal muscle mass for immunotherapy with nivolumab in nonsmall cell lung cancer patients: A "hypothesis-generator" preliminary report: Sarcopenia in NSCLC, Thorac Cancer. févr, vol.10, issue.2, pp.347-51, 2019.

N. Nishioka, J. Uchino, S. Hirai, Y. Katayama, A. Yoshimura et al., Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer, J Clin Med. 3 avr, vol.8, issue.4, p.450, 2019.

T. Shiroyama, I. Nagatomo, S. Koyama, H. Hirata, S. Nishida et al., Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study, Sci Rep. déc, vol.9, issue.1, 2019.

V. Heidelberger, F. Goldwasser, N. Kramkimel, A. Jouinot, O. Huillard et al., Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients, Invest New Drugs. août, vol.35, issue.4, pp.436-477, 2017.

E. A. Eisenhauer, P. Therasse, J. Bogaerts, L. H. Schwartz, D. Sargent et al., New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1), Eur J Cancer. janv, vol.45, issue.2, pp.228-275, 2009.

H. Kruizenga, S. Van-keeken, P. Weijs, L. Bastiaanse, S. Beijer et al., Undernutrition screening survey in 564,063 patients: patients with a positive undernutrition screening score stay in hospital 1.4 d longer, Am J Clin Nutr. 1 avr, vol.103, issue.4, pp.1026-1058, 2016.

M. Pressoir, S. Desné, D. Berchery, G. Rossignol, B. Poiree et al., Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres, Br J Cancer. mars, vol.102, issue.6, pp.966-71, 2010.

R. Rami-porta, V. Bolejack, D. J. Giroux, K. Chansky, J. Crowley et al., The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer, J Thorac Oncol, vol.9, issue.11, pp.1618-1642, 2014.

G. Wie, Y. Cho, S. Kim, S. Kim, J. Bae et al., Prevalence and risk factors of malnutrition among cancer patients according to tumor location and stage in the National Cancer Center in Korea, Nutrition. mars, vol.26, issue.3, pp.263-271, 2010.

E. B. Garon, N. A. Rizvi, R. Hui, N. Leighl, A. S. Balmanoukian et al., Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer, N Engl J Med. 21 mai, vol.372, issue.21, pp.2018-2046, 2015.

L. Horn, D. R. Spigel, E. E. Vokes, E. Holgado, N. Ready et al., Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057), J Clin Oncol. 10 déc, vol.35, issue.35, pp.3924-3957, 2017.

C. K. Lee, J. Man, S. Lord, W. Cooper, M. Links et al., Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non-Small Cell Lung Carcinoma: A Systematic Review and Meta-analysis, JAMA Oncol. 1 févr, vol.4, issue.2, p.210, 2018.

G. Popinat, S. Cousse, L. Goldfarb, S. Becker, I. Gardin et al., Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumab, OncoImmunology. 4 mai, vol.8, issue.5, p.1580128, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02342305

F. M. Wensveen, S. Valenti?, M. ?estan, T. Turk-wensveen, and B. Poli?, Interactions between adipose tissue and the immune system in health and malnutrition, Semin Immunol. sept, vol.27, issue.5, pp.322-355, 2015.

V. E. Baracos, L. Martin, M. Korc, D. C. Guttridge, and K. Fearon, Cancer-associated cachexia, Nat Rev Dis Primer. juin, vol.4, issue.1, 2018.